Search

Your search keyword '"Bertz, H"' showing total 722 results
Start Over Author "Bertz, H"

Refine your results

722 results on '"Bertz, H"'

8. Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.

Author

Maertens, J., Lodewyck, T., Donnelly, J.P., Chantepie, S., Robin, C., Blijlevens, N.M., Turlure, P., Selleslag, D., Baron, F., Aoun, M., Heinz, W.J., Bertz, H., Ráčil, Z., Vandercam, B., Drgona, L., Coiteux, V., Llorente, C.C., Schaefer-Prokop, C.M., Paesmans, M., Ameye, L., Meert, L., Cheung, K.J., Hepler, D.A., Loeffler, J., Barnes, R., Marchetti, O., Verweij, P.E., Lamoth, F., Bochud, P.Y., Schwarzinger, M., Cordonnier, C., Maertens, J., Lodewyck, T., Donnelly, J.P., Chantepie, S., Robin, C., Blijlevens, N.M., Turlure, P., Selleslag, D., Baron, F., Aoun, M., Heinz, W.J., Bertz, H., Ráčil, Z., Vandercam, B., Drgona, L., Coiteux, V., Llorente, C.C., Schaefer-Prokop, C.M., Paesmans, M., Ameye, L., Meert, L., Cheung, K.J., Hepler, D.A., Loeffler, J., Barnes, R., Marchetti, O., Verweij, P.E., Lamoth, F., Bochud, P.Y., Schwarzinger, M., and Cordonnier, C.

Abstract

Item does not contain fulltext, BACKGROUND: Empiric antifungal therapy is considered the standard of care for high-risk neutropenic patients with persistent fever. The impact of a preemptive, diagnostic-driven approach based on galactomannan screening and chest computed tomography scan on demand on survival and on the risk of invasive fungal disease (IFD) during the first weeks of high-risk neutropenia is unknown. METHODS: Patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and allogeneic hematopoietic cell transplant recipients were randomly assigned to receive caspofungin empirically (arm A) or preemptively (arm B), while receiving fluconazole 400 mg daily prophylactically. The primary end point of this noninferiority study was overall survival (OS) 42 days after randomization. RESULTS: Of 556 patients recruited, 549 were eligible: 275 in arm A and 274 in arm B. Eighty percent of the patients had AML or MDS requiring high-dose chemotherapy, and 93% of them were in the first induction phase. At day 42, the OS was not inferior in arm B (96.7%; 95% confidence interval [CI], 93.8%-98.3%) when compared with arm A (93.1%; 95% CI, 89.3%-95.5%). The rates of IFDs at day 84 were not significantly different, 7.7% (95% CI, 4.5%-10.8%) in arm B vs 6.6% (95% CI, 3.6%-9.5%) in arm A. The rate of patients who received caspofungin was significantly lower in arm B (27%) than in arm A (63%; P < .001). CONCLUSIONS: The preemptive antifungal strategy was safe for high-risk neutropenic patients given fluconazole as prophylaxis, halving the number of patients receiving antifungals without excess mortality or IFDs. Clinical Trials Registration. NCT01288378; EudraCT 2010-020814-27.

Published
2023

9. Gastroenterologie

Author

Rungger, M., Wöllner, T., Nekahm-Heis, D., Vanek, S., Pototschnig, C., Freyschlag, H., Patjas, M., Pall, C., Galvan, O., Tilg, H., Meier, R., Wermuth, J., Stanga, Z., Neidl, D., Ledochowski, M., Bertz, H., Schmitting-Ulrich, S., Graziadei, I., Zoller, H., Koch, R., Vogel, W., Kafka-Ritsch, R., Hutter, G., and Ledochowski, Maximilian, editor

Published
2010
Full Text
View/download PDF

10. Improvement in the outcome of invasive fusariosis in the last decade

Author

Nucci, M., Marr, K.A., Vehreschild, M.J.G.T., de Souza, C.A., Velasco, E., Cappellano, P., Carlesse, F., Queiroz-Telles, F., Sheppard, D.C., Kindo, A., Cesaro, S., Hamerschlak, N., Solza, C., Heinz, W.J., Schaller, M., Atalla, A., Arikan-Akdagli, S., Bertz, H., Galvão Castro, C., Jr, Herbrecht, R., Hoenigl, M., Härter, G., Hermansen, N.E.U., Josting, A., Pagano, L., Salles, M.J.C., Mossad, S.B., Ogunc, D., Pasqualotto, A.C., Araujo, V., Troke, P.F., Lortholary, O., Comely, O.A., and Anaissie, E.

Published
2014
Full Text
View/download PDF

20. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Author

Zeiser, R, Burchert, A, Lengerke, C, Verbeek, M, Maas-Bauer, K, Metzelder, S K, Spoerl, S, Ditschkowski, M, Ecsedi, M, Sockel, K, Ayuk, F, Ajib, S, de Fontbrune, F S, Na, I-K, Penter, L, Holtick, U, Wolf, D, Schuler, E, Meyer, E, Apostolova, P, Bertz, H, Marks, R, Lübbert, M, Wäsch, R, Scheid, C, Stölzel, F, Ordemann, R, Bug, G, Kobbe, G, Negrin, R, Brune, M, Spyridonidis, A, Schmitt-Gräff, A, van der Velden, W, Huls, G, Mielke, S, Grigoleit, G U, Kuball, J, Flynn, R, Ihorst, G, Du, J, Blazar, B R, Arnold, R, Kröger, N, Passweg, J, Halter, J, Socié, G, Beelen, D, Peschel, C, Neubauer, A, Finke, J, Duyster, J, and von Bubnoff, N

Published
2015
Full Text
View/download PDF

23. Interprofessional evidence-based counselling programme for complementary and integrative healthcare in patients with cancer: study protocol for the controlled implementation study CCC-Integrativ

Author

Valentini, J., Fröhlich, D., Stolz, R., Mahler, C., Martus, P., Klafke, N., Horneber, M., Frasch, J., Kramer, K., Bertz, H., Grün, B., Wensing, M., Tomaschko-Ubeländer, K., Joos, S., Valentini, J., Fröhlich, D., Stolz, R., Mahler, C., Martus, P., Klafke, N., Horneber, M., Frasch, J., Kramer, K., Bertz, H., Grün, B., Wensing, M., Tomaschko-Ubeländer, K., and Joos, S.

Abstract

Item does not contain fulltext, INTRODUCTION: According to international literature, patients with cancer wish to have information on complementary and integrative healthcare (CIH). Medical guidelines recommend actively approaching patients with cancer discussing potential benefits and risks of individual CIH methods. While some CIH methods, for example, acupuncture and yoga, have been proven effective in high-quality studies, other CIH methods lack studies or bear the risk of interactions with chemotherapeutics, for example, herbal drugs. Therefore, an evidence-based interprofessional counselling programme on CIH will be implemented at four Comprehensive Cancer Centres in the federal state of Baden-Wuerttemberg, Germany. METHODS AND ANALYSIS: A complex intervention consisting of elements on patient, provider and system levels will be developed and evaluated within a multilayer evaluation design with confirmatory evaluation on patient level. Patients with a cancer diagnosis within the last 6 months will receive three individual counselling sessions on CIH within 3 months (=intervention on patient level). The counselling will be provided by an interprofessional team of medical and nursing staff. For this purpose, an intensive online training programme, a CIH knowledge database and an interprofessional team-building process were developed and implemented (=intervention on provider level). Moreover, training events on the basics of CIH are offered in the outpatient setting (=intervention on system level). Primary outcome of the evaluation at the patient level is patient activation measured (PAM) with the PAM-13 after 3 months. Secondary outcomes, for example, quality of life, self-efficacy and clinical parameters, will be assessed at baseline, after 3 months and at 6 months follow-up. The intervention group (n=1000) will be compared with a control group (n=500, treatment as usual, no CIH counselling. The outcomes and follow-up times in the control group are the same as in the intervention group. More

Published
2022

50. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project

Author

Dettenkofer, M., Wenzler-Rottele, S., Babikir, R., Bertz, H., Ebner, W., Meyer, E., Ruden, H., Gastmeier, P., and Daschner, F.D.

Subjects
Bacterial pneumonia -- Diagnosis, Bacterial pneumonia -- Care and treatment, Pneumonia -- Diagnosis, Pneumonia -- Care and treatment, Bacterial infections -- Diagnosis, Bacterial infections -- Care and treatment, Health, Health care industry
Published
2005

Catalog

Books, media, physical & digital resources
See catalog results